PNAS

FDA must regulate stem cell therapies to mitigate risks to patients and the public

• Taylor Pike
• Mary Ann Chirba
• Daniel G. Aaron

2026-03-11

Full text

DOI https://doi.org/10.1073/pnas.2508586123